Jane Street Group, LLC Silverback Therapeutics, Inc. Transaction History

Jane Street Group, LLC

  • $72.9 Billion
  • Q1 2024

A detailed history of Jane Street Group, LLC transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 92,328 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
92,328
Previous 88,165 4.72%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
N/A
4,163 Added 4.72%
92,328 $0
Q4 2023

Feb 14, 2024
BUY
N/A
66,713 Added 310.99%
88,165 $0
Q3 2023

Nov 14, 2023
SELL
N/A
-4,391 Reduced 16.99%
21,452 $0
Q2 2023

Aug 14, 2023
SELL
N/A
-111,607 Reduced 81.2%
25,843 $0
Q1 2023

May 15, 2023
BUY
N/A
117,793 Added 599.24%
137,450 $0
Q4 2022

Feb 14, 2023
BUY
$0.0 - $6.07 $0 - $33,227
5,474 Added 38.6%
19,657 $0
Q3 2022

Nov 14, 2022
BUY
$3.91 - $5.52 $55,455 - $78,290
14,183 New
14,183 $75,000
Q3 2021

Nov 16, 2021
SELL
$9.98 - $35.22 $90,927 - $320,889
-9,111 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$24.71 - $44.28 $225,132 - $403,435
9,111 New
9,111 $281,000
Q1 2021

May 18, 2021
SELL
$37.62 - $60.41 $716,209 - $1.15 Million
-19,038 Closed
0 $0
Q4 2020

Feb 17, 2021
BUY
$25.0 - $46.34 $475,950 - $882,220
19,038 New
19,038 $882,000

Others Institutions Holding SBTX

# of Institutions
117
Shares Held
47.9M
Call Options Held
442K
Put Options Held
42K
View Full List

About Silverback Therapeutics, Inc.

SBTX Quotes by TradingView
  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email